Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Discover index funds with standout Sharpe ratios over the last ten years and learn how risk-adjusted performance translates into better risk management.
28,172 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A single family moment can reveal big money lessons. This article turns a pop culture moment into actionable steps fo...
A leading economist warns that renewed hostilities with Iran could trigger a butterfly effect in global markets, keep...
A strategic expansion at Energy Transfer's Nederland NGL Export Terminal aims to boost export capacity and support a ...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
A global AI buildout is hitting the power spine, driving a 300% pricing surge for gas turbines. GE Vernova faces a pi...
Fresh data on unemployment filings show the labor market staying resilient. The big question remains whether the econ...
Retiring to Key West on a $1.6 million portfolio at age 62 faces steep housing costs and high insurance. This report ...
OpenAI CEO Sam Altman notes a sharp generational divide in how ChatGPT is used, with Millennials seeking personal fin...
Micron unveils a $200 billion expansion to meet AI memory demand, and the company says even customers couldn’t foreca...
Supreme Lending adds a Houston-based team with over $100 million in annual loan production, strengthening its Texas f...
Mark Zuckerberg showcased a bold use of wearable tech by taking a business call from a jet ski, underscoring Meta's p...